General
Preferred name
(RS)-(Tetrazol-5-yl)glycine
Synonyms
tetrazol-5-yl-glycine-(RS) ()
(RS)-(tetrazol-5-yl)glycine ()
Tetrazolyl Glycine ()
P&D ID
PD035713
CAS
138199-51-6
Tags
available
drug candidate
Drug indication
Discovery agent
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Endogenous agonist
(Tocris Bioactive Compound Library)
DESCRIPTION
Highly potent NMDA receptor agonist
(Tocriscreen Total)
DESCRIPTION
(RS)-(Tetrazol-5-yl)glycine is a highly potent NMDA receptor agonist demonstrating 20 times more active than NMDA.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
12
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
DrugMAP
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
Tocris Bioactive Compound Library
Tocriscreen Total
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
19
Properties
(calculated by RDKit )
Molecular Weight
143.04
Hydrogen Bond Acceptors
5
Hydrogen Bond Donors
3
Rotatable Bonds
2
Ring Count
1
Aromatic Ring Count
1
cLogP
-1.72
TPSA
117.78
Fraction CSP3
0.33
Chiral centers
1.0
Largest ring
5.0
QED
0.45
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Primary Target
NMDA Receptors
MOA
Agonist
Source data